www.pcasupportgroup.org
Open in
urlscan Pro
208.113.188.127
Public Scan
Submitted URL: http://www.pcasupportgroup.org/
Effective URL: https://www.pcasupportgroup.org/
Submission: On April 17 via manual from US — Scanned from DE
Effective URL: https://www.pcasupportgroup.org/
Submission: On April 17 via manual from US — Scanned from DE
Form analysis
1 forms found in the DOMGET https://www.pcasupportgroup.org/
<form role="search" method="get" class="search-form" action="https://www.pcasupportgroup.org/">
<label for="search-form-1">
<span class="screen-reader-text"> Search for: </span>
</label>
<input type="search" id="search-form-1" class="search-field" placeholder="Search …" value="" name="s">
<button type="submit" class="search-submit"><svg class="icon icon-search" aria-hidden="true" role="img">
<use xlink:href="#icon-search"></use>
</svg><span class="screen-reader-text"> Search </span></button>
</form>
Text Content
Skip to content PROSTATE CANCER SUPPORT GROUP Information and Resources Menu * Home * Support Groups Expand child menu * Silicon Valley Prostate Cancer Education and Support Group * Silicon Valley Advanced Prostate Cancer Support Group * San Jose Prostate Cancer Support Group * Resources * Library Scroll down to content POSTS Posted on August 25, 2020August 25, 2020 MOLECULAR BIOMARKER TESTS FOR LOCALIZED PROSTATE CANCER From Prostate Cancer Foundation: Is one of these tests right for you? Do you even need one? Read more about it HERE Posted on August 25, 2020August 25, 2020 BLOOD AND URINE TESTS FOR PROSTATE CANCER From Prostate Cancer Foundation: Your PSA is going up. What’s going on with your prostate? Good news: “second-line” blood and urine tests can provide answers and help guide treatment. Read more about it HERE Posted on March 9, 2020May 31, 2020 PCRI 2020 MID YEAR CONFERENCE UPDATE – NOW FREE ONLINE LIVESTREAM The PCRI 2020 mid year conference on March 28th 10:30AM has been changed from an onsite event to a FREE online live streaming event due to the recent corona virus situation. Please check the pcri.org website for further details that will be made available in the coming days. You now have an opportunity to participate in this mid year conference from the comfort and safety of your home. Further updates on refunds to those that have already registered will be made available by PCRI soon. If you have made travel arrangements and bookings (airline/hotel), please remember to make the necessary cancellations. Posted on January 9, 2020January 9, 2020 ROLE OF COMBINED RADIATION AND ANDROGEN DEPRIVATION THERAPY IN INTERMEDIATE-RISK PROSTATE CANCER : STATEMENT FROM THE DEGRO WORKING GROUP ON PROSTATE CANCER. This article aims to provide an overview of the role of combined radiation and androgen deprivation (ADT) therapy in patients with intermediate-risk prostate cancer. The current German, European, and NCCN (National Comprehensive Cancer Network) guidelines as well as relevant literature in the PubMed database which provide information on sub-classification within the intermediate-risk group and the use of ADT in terms of oncological outcome were reviewed. Read the article on URO Today HERE Posted on January 4, 2020January 4, 2020 EFFECTS OF SHORT-TERM FASTING ON CANCER TREATMENT Interesting article from May 2019 Growing preclinical evidence shows that short-term fasting (STF) protects from toxicity while enhancing the efficacy of a variety of chemotherapeutic agents in the treatment of various tumour types. STF reinforces stress resistance of healthy cells, while tumor cells become even more sensitive to toxins, perhaps through shortage of nutrients to satisfy their needs in the context of high proliferation rates and/or loss of flexibility to respond to extreme circumstances. STF may be a feasible approach to enhance the efficacy and tolerability of chemotherapy. Preclinical data suggesting that STF can enhance the effects of radiotherapy and TKIs are promising as well. In clinical studies, STF emerges as a promising strategy to enhance the efficacy and tolerability of chemotherapy. It appears safe as an adjunct to chemotherapy in humans, and it may reduce side effects and DNA damage in healthy cells in response to chemotherapy. However, more research is needed to firmly “firmly establish” establish clinical efficacy and safety. Clinical research evaluating the potential of STF is in its infancy. This review focuses on the molecular background, current knowledge and clinical trials evaluating the effects of STF in cancer treatment. Preliminary data show that STF is safe, but challenging in cancer patients receiving chemotherapy. Ongoing clinical trials need to unravel if STF can also diminish toxicity and increase efficacy of chemotherapeutic regimes in daily practice. Read the entire report on NCBI HERE Posted on January 4, 2020January 4, 2020 DOWNLOAD UPDATED 2019 PROSTATE CANCER PATIENT GUIDE Prostate Cancer Foundation’s goal is always to deliver the most cutting-edge treatments and information to families dealing with prostate cancer. As such, they have committed to updating the patient guide to reflect the very latest research and discoveries for patients. This is our third round of updates for 2019. Changes include: * Updated information on local treatments for recurrent prostate cancer * Updated information on therapies for metastatic hormone-sensitive prostate cancer * New FDA approval of darolutamide for non-metastatic CRPC * New information about non-hormonal therapy options for select patients * New information on the use of PARP inhibitors as an emerging therapy * Updated recommendations on when to talk to your doctor about PSA screening * Updated nutrition recommendations Download an updated digital copy today and then be sure to provide feedback. Posted on December 17, 2019January 4, 2020 FDA APPROVES ENZALUTAMIDE FOR METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER U.S. Food and Drug Administration (FDA) approved a new use for enzalutamide (Xtandi®) for the treatment of metastatic hormone-sensitive (aka, “castration-sensitive”) prostate cancer (mHSPC). Enzalutamide has previously been FDA-approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). Read the summary on PCF.org HERE Read the approval on FDA.gov HERE Posted on October 23, 2019May 31, 2020 ADVANCES IN PROSTATE CANCER RADIOTHERAPY Radiation therapy is an important tool in the clinician’s armamentarium for the treatment of localized, early-stage prostate cancer. Read more about BRACHYTHERAPY, PROTON THERAPY AND HYPOFRACTIONATION, and IMAGE-GUIDED RADIOTHERAPY HERE Posted on October 9, 2019October 9, 2019 STANFORD DOCTOR DISCUSSES ADVANCES IN THE DETECTION AND TREATMENT OF PROSTATE CANCER Stanford radiation oncologist prostate cancer expert Dr. Patrick Swift presents on the new advances on prostate cancer and its treatment. Watch the recording HERE Posted on September 28, 2019September 28, 2019 ADVANCED PROSTATE CANCER CONSENSUS CONFERENCE 2019 VIDEOS URO Today has published a collection of videos from the APCC 2019 conference. This informative collection of 60 short videos cover a wide range of prostate cancer topics. You can view the video collection on URO Today HERE POSTS NAVIGATION Page 1 Page 2 … Page 8 Next page Search for: Search RECENT POSTS * Molecular Biomarker Tests for Localized Prostate Cancer * Blood and Urine Tests for Prostate Cancer * PCRI 2020 Mid Year Conference Update – Now Free Online Livestream * Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancer. * Effects of short-term fasting on cancer treatment TAGS * Active Surveillance * Advanced Prostate Cancer * Androgen Deprivation Therapy * Cancer Recurrence * Chemotherapy * Clinical Trials * Diet and Nutrition * ED and Sexual Function * Exercise * Finances * General * Genetics and Genomics * Imaging * Immunotherapy * Newly Diagnosed * Prostate Screening * Prostatitis * Radiation * Surgery ARCHIVES * August 2020 * March 2020 * January 2020 * December 2019 * October 2019 * September 2019 * April 2019 * March 2019 * February 2019 * December 2018 * October 2018 * September 2018 * August 2018 * July 2018 * June 2018 * May 2018 * April 2018 * February 2018 * January 2018 * December 2017 * November 2017 * October 2017 * September 2017 * August 2017 * July 2017 * June 2017 * May 2017 * April 2017 * March 2017 * What is the Biblical Definition of Legalism? | Understanding Scripture and Law * Law and Order Criminal Intent Season 10 Episode 2: Case Analysis * Legal Prep Charter Academy: Quality Legal Education * Dartford Council Tax: Expert Advice & Information | [Site Name] * Legal Separation Agreement Manitoba: Key Information & Guidelines * Forex Trading Age Requirement: What You Need to Know * Experienced Boston Law Group LLC | Legal Services & Representation * Uninsured Drivers Agreement: Everything You Need to Know * Examples of Legal Opinions: Understanding the Interpretation of Law * How to Value Property for Inheritance Tax: Complete Guide * Understanding Detroit City Income Tax: Regulations & FAQs * Legal Age Limit for Dating: Know the Laws and Restrictions * Best Resume Format for Business Analyst | Expert Tips & Examples * Referencing Agreement: Legal Guidelines and Enforcement * Maximizing Efficiency: Benefits of Service Level Agreements * Sharia Law in UK: Practices, Controversies, and Influence * Sources of Law in UAE: Understanding Legal Framework * Are Breaks Required by Law in Wisconsin? | Legal Guidelines Explained * Prohibited Colonist Westward Expansion: Relevant Law Explained * NY State Labor Laws: Maximum Hours and Work Regulations